Aortic stenosis has traditionally been addressed with surgical aortic valve replacement with a stented prosthesis. Several technologies have emerged as an alternative treatment method for aortic valve disease. Among them, Perceval Sutureless valve has been used in clinical practice for more than a decade. The aim of this study was to evaluate the results of Perceval Sutureless valve from single centre in Indian population. Between April 2018 to December 2021, 30 elective patients underwent aortic valve replacement with the Perceval Sutureless valve. 19 patients had isolated AVR and 11 patients underwent AVR + Coronary artery bypass grafting (CABG) with average grafts 2.1 ± 0.8. Majority of isolated AVR, 12 of 19, were done by minimally invasive approach. Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ± 1.5. Mean aortic cross clamp time for isolated AVR and combined procedure were 42 ± 11 and 74 ± 23 respectively. There was no in-hospital mortality. 3 patients required ventilation for > 24 hours. New onset left bundle branch block occurred in 4 patients which recovered before discharge in 2 patients. The peak and mean valve gradients were satisfactory. None of implanted valve showed para-valvular leak. SAVR using Perceval Sutureless valve is associated with excellent results and represent a safe and effective treatment option for patients with severe AS. This valve also facilitates MI approach and reduces aortic x-clamp and cardiopulmonary bypass time.
| Published in | International Journal of Cardiovascular and Thoracic Surgery (Volume 8, Issue 3) |
| DOI | 10.11648/j.ijcts.20220803.12 |
| Page(s) | 29-34 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Aortic Stenosis, AVR, Minimally Invasive Surgery, Sutureless Valve
| [1] | Rosu, C., Soltesz, E. G. Selection of valve prostheses. Semin Thorac Cardiovasc Surg. 2015; 27: 152–158. |
| [2] | Carabello, B. A. Is it ever too late to operate on the patient with valvular heart disease? J Am Coll Cardiol. 2004; 44: 376–383. |
| [3] | Shrestha M, Folliguet T, Meuris B, et al. Sutureless Perceval S aortic valve replacement: A multicenter, prospective pilot trial. J Heart Valve Dis 2009; 18: 698-702. |
| [4] | C. N. Manjunath, P. Srinivas, K. S. Ravindranath et al. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: A single center experience, Indian Heart J. 2014 May; 66 (3): 320–326. |
| [5] | Mohr FW., Holzhey D., Möllmann H et al. The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 2014; 46: 808–816. |
| [6] | Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med 2010; 363: 1597-607. |
| [7] | Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-20. |
| [8] | Gilbert H. L. Tang, Subodh Verma, Deepak L. Bhatt Transcatheter Aortic Valve Replacement in Low-Risk patients – A New Era in the Treatment of Aortic Stenosis, Circulation. 2019; 140: 801-803. |
| [9] | Kunal V. Patel, Wally Omar, Pedro Engel Gonzalez et al, Expansion of TAVR into Low-Risk Patients and Who Consider for SAVR, Cardiol Ther 2020; 9: 377 – 394. |
| [10] | S. Hamed Alavi, Elliott M. Groves, Arash Kheradvar, The Effects of Transcatheter Valve Crimping on Pericardial Leaflets Ann Thorac Surg 2014; 97: 1260–6. |
| [11] | Bana A; TAVR—present, future, and challenges in developing countries Indian Journal of Thoracic and Cardiovascular Surgery volume 2019; 35, 473–484. |
| [12] | Pollari, F., Santarpino, G., Dell'Aquila, A. M. Better short-term outcome by using sutureless valves: a propensity-matched score analysis. Ann Thorac Surg. 2014; 98: 611–616. |
| [13] | Santarpino, G., Pfeiffer, S., Concistré, G. et al. The Perceval S aortic valve has the potential of shortening surgical time: does it also result in improved outcome? Ann Thorac Surg. 2013; 96: 77–81. |
| [14] | Meco M., Montisci A., Miceli A. et al. Sutureless Perceval aortic valve versus conventional stented bioprostheses: meta-analysis of postoperative and midterm results in isolated aortic valve replacement. J Am Heart Assoc. 2018; 7: 1-9. |
| [15] | Ferdinand Vogt, Marco Moscarelli, Anna Nicoletti et al. Sutureless aortic valve and pacemaker rate: from surgical tricks to clinical outcomes Ann Thorac Surg. 2019 Jul; 108 (1): 99-105. |
| [16] | Delphine Szecel, Roxanne Eurlings, Filip Rega et al. Perceval sutureless aortic valve implantation: mid-term outcomes. Ann Thorac Surg. 2021 Apr; 111 (4): 1331-1337. |
| [17] | Ranucci M, Frigiola A, Menicanti L, Castelvecchio A et al. Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement. J. Heart Valve Dis 2012; 21: 732–9. |
| [18] | Theodor Fischlein, Thierry Folliguet, Bart Meuris et al. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis. J Thorac Cardiovasc Surg. 2021 Mar; 161 (3): 920-932. |
| [19] | Giuseppe Santarpino, Paolo Berretta, Theodor Fischlein et al. Operative outcome of patient at low, intermediate, high and ‘very high’ surgical risk undergoing isolated aortic valve replacement with sutureless and rapid deployment prostheses: results of the SURD-IR registry. Eur J Cardiothorac Surg 2019 Jul 1; 56 (1): 38-43. |
| [20] | Marco Solinas, Giacomo Bianchi, Francesca Chiaramonti et al, Right anterior mini-thoracotomy and sutureless valves: the perfect marriage. Ann Cardiothorac Surg. 2020 Jul; 9 (4): 305-313. |
| [21] | Miceli A, Santarpino G, Pfeiffer S et al. Minimally invasive aortic valve replacement with Perceval S sutureless valve: Early outcomes and one-year survival from two European centers. J Thorac Cardiovasc Surg 2014; 148: 2838-43. |
| [22] | Bouhout I, Mazine A, Rivard L et al. Conduction Disorders After Sutureless Aortic Valve Replacement. Ann Thorac Surg 2017; 103: 1254-60. |
| [23] | Dalén M, Biancari F, Rubino AS et al. Aortic valve replacement through full sternotomy with a stented bioprosthesis versus minimally invasive sternotomy with a sutureless bioprosthesis. Eur J Cardiothorac Surg 2016; 49: 220-7. |
| [24] | Paolo Berretta, Martin Andreas, Thierry P Carrel et al. Minimally invasive aortic valve replacement with sutureless and rapid deployment valve: a report from an international registry (Sutureless and Rapid Deployment International Registry). Eur J Cardiothorac Surg 2019 Oct 1; 56 (4): 793-799. |
| [25] | Siontis GC, Praz F, Pilgrim T et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 2016; 37: 3503-12. 10. 1093. |
| [26] | D'Onofrio A, Salizzoni S, Rubino AS et al. The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation. J Thorac Cardiovasc Surg 2016; 152: 99-109. |
| [27] | Santarpino G, Pfeiffer S, Jessl J et al. Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: A propensity-matched analysis of 2 strategies in high-risk patients. J Thorac Cardiovasc Surg 2014; 147: 561-7. |
| [28] | Mattia Glauber, MD, Lorenzo Di Bacco, MD, Jose Cuenca, MD et al. Minimally Invasive Aortic Valve Replacement with Sutureless Valve: Results From an International Registry. Innovations Volume: 15 issue: 2, page (s): 120-130. |
| [29] | Thyregod HG, Steinbru¨chel DA, Ihlemann N et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the allcomers NOTION randomized clinical trial. J Am Coll Cardiol 2015; 65: 2184–94. |
APA Style
Ajeet Bana, Saurabh Jaiswal, Vimalkant Yadav, Mukta Tiwari, Anuj Sangal. (2022). Perceval Sutureless Valve - A Limbo Concept or a Future Trial. International Journal of Cardiovascular and Thoracic Surgery, 8(3), 29-34. https://doi.org/10.11648/j.ijcts.20220803.12
ACS Style
Ajeet Bana; Saurabh Jaiswal; Vimalkant Yadav; Mukta Tiwari; Anuj Sangal. Perceval Sutureless Valve - A Limbo Concept or a Future Trial. Int. J. Cardiovasc. Thorac. Surg. 2022, 8(3), 29-34. doi: 10.11648/j.ijcts.20220803.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcts.20220803.12,
author = {Ajeet Bana and Saurabh Jaiswal and Vimalkant Yadav and Mukta Tiwari and Anuj Sangal},
title = {Perceval Sutureless Valve - A Limbo Concept or a Future Trial},
journal = {International Journal of Cardiovascular and Thoracic Surgery},
volume = {8},
number = {3},
pages = {29-34},
doi = {10.11648/j.ijcts.20220803.12},
url = {https://doi.org/10.11648/j.ijcts.20220803.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20220803.12},
abstract = {Aortic stenosis has traditionally been addressed with surgical aortic valve replacement with a stented prosthesis. Several technologies have emerged as an alternative treatment method for aortic valve disease. Among them, Perceval Sutureless valve has been used in clinical practice for more than a decade. The aim of this study was to evaluate the results of Perceval Sutureless valve from single centre in Indian population. Between April 2018 to December 2021, 30 elective patients underwent aortic valve replacement with the Perceval Sutureless valve. 19 patients had isolated AVR and 11 patients underwent AVR + Coronary artery bypass grafting (CABG) with average grafts 2.1 ± 0.8. Majority of isolated AVR, 12 of 19, were done by minimally invasive approach. Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ± 1.5. Mean aortic cross clamp time for isolated AVR and combined procedure were 42 ± 11 and 74 ± 23 respectively. There was no in-hospital mortality. 3 patients required ventilation for > 24 hours. New onset left bundle branch block occurred in 4 patients which recovered before discharge in 2 patients. The peak and mean valve gradients were satisfactory. None of implanted valve showed para-valvular leak. SAVR using Perceval Sutureless valve is associated with excellent results and represent a safe and effective treatment option for patients with severe AS. This valve also facilitates MI approach and reduces aortic x-clamp and cardiopulmonary bypass time.},
year = {2022}
}
TY - JOUR T1 - Perceval Sutureless Valve - A Limbo Concept or a Future Trial AU - Ajeet Bana AU - Saurabh Jaiswal AU - Vimalkant Yadav AU - Mukta Tiwari AU - Anuj Sangal Y1 - 2022/06/09 PY - 2022 N1 - https://doi.org/10.11648/j.ijcts.20220803.12 DO - 10.11648/j.ijcts.20220803.12 T2 - International Journal of Cardiovascular and Thoracic Surgery JF - International Journal of Cardiovascular and Thoracic Surgery JO - International Journal of Cardiovascular and Thoracic Surgery SP - 29 EP - 34 PB - Science Publishing Group SN - 2575-4882 UR - https://doi.org/10.11648/j.ijcts.20220803.12 AB - Aortic stenosis has traditionally been addressed with surgical aortic valve replacement with a stented prosthesis. Several technologies have emerged as an alternative treatment method for aortic valve disease. Among them, Perceval Sutureless valve has been used in clinical practice for more than a decade. The aim of this study was to evaluate the results of Perceval Sutureless valve from single centre in Indian population. Between April 2018 to December 2021, 30 elective patients underwent aortic valve replacement with the Perceval Sutureless valve. 19 patients had isolated AVR and 11 patients underwent AVR + Coronary artery bypass grafting (CABG) with average grafts 2.1 ± 0.8. Majority of isolated AVR, 12 of 19, were done by minimally invasive approach. Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ± 1.5. Mean aortic cross clamp time for isolated AVR and combined procedure were 42 ± 11 and 74 ± 23 respectively. There was no in-hospital mortality. 3 patients required ventilation for > 24 hours. New onset left bundle branch block occurred in 4 patients which recovered before discharge in 2 patients. The peak and mean valve gradients were satisfactory. None of implanted valve showed para-valvular leak. SAVR using Perceval Sutureless valve is associated with excellent results and represent a safe and effective treatment option for patients with severe AS. This valve also facilitates MI approach and reduces aortic x-clamp and cardiopulmonary bypass time. VL - 8 IS - 3 ER -
Information
Email: